keywords:LGD-4033,LGD-4033

Product Quick Detail

Minimum Order
1
Packaging
N/A
Delivery
15 Days

How LGD-4033 works
LGD-4033, a novel nonsteroidal, oral selective androgen receptor modulator, binds to the androgen receptor with high affinity and selectivity. It demonstrates anabolic activity in muscles, anti-resorptive and anabolic activity in bones and a robust selectivity for muscle and bone versus prostate and sebaceous glands. LGD-4033 has recently completed a Phase I Multiple Ascending Dose study in healthy volunteers. This randomized, double-blind, placebo-controlled Phase I study established the safety and tolerability up to doses of 22 mg per day.

LGD-4033 Uses

  • Country: China (Mainland)
  • Business Type: Trading Company
  • Market: Americas,Europe,Middle East
  • Founded Year: 2001
  • Contact: Celine Yu

hubei yuancheng SAISI

Enter between 20 to 3,000 characters. English only. Characters: 0 / 3000
submiting now We do inquire for you, please wait...